Healthcare Services

Adenosine Triphosphate (ATP) Assays Market Developments Influencing Industry Expansion Through 2030

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Adenosine Triphosphate (ATP) Assays Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The adenosine triphosphate (atp) assays market has experienced substantial expansion recently. Projections indicate its value will escalate from $2.19 billion in 2025 to $2.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. This historical increase can be ascribed to several factors, including the constrained supply of high-sensitivity atp assay kits, a dependence on conventional biochemical assays, expanding pharmaceutical research initiatives, wider implementation of molecular biology methods, and the escalating importance of food safety and environmental oversight.

The adenosine triphosphate (atp) assays market is projected to undergo significant expansion in the coming years. It is expected to grow to **$3.88 billion** in **2030**, achieving a compound annual growth rate (CAGR) of **12.2%**. This anticipated growth stems from the development of high-throughput ATP assay platforms, increasing integration with automated laboratory instruments, rising applications in clinical diagnostics and personalized medicine, the expansion of biotechnology research and drug development, and advancements in fluorescent and luminescent assay technologies. Key trends for the forecast period include the growing adoption of ATP assays in drug discovery, increasing use of cell-based assays for viability and cytotoxicity testing, the expansion of ATP assays into food safety and environmental testing, a growing demand for luminometric and enzymatic ATP assays, and an enhanced focus on assay sensitivity, accuracy, and standardization.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10767&type=smp

What Influential Factors Are Boosting The Adenosine Triphosphate (ATP) Assays Market Demand?

The increasing incidence of cancer, chronic illnesses, and infectious diseases is projected to fuel the expansion of the adenosine triphosphate (ATP) assay market moving forward. Cancer is defined by uncontrolled cellular proliferation that can invade and harm surrounding tissues, potentially spreading to other body parts. Chronic diseases are stable conditions that typically advance slowly and persist for an extended duration. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, and are capable of spreading between individuals. ATP assays offer a valuable method for diagnosing these conditions by assessing cellular viability, detecting microbial contamination, evaluating treatment efficacy, and monitoring metabolic and mitochondrial dysfunction. For instance, in February 2024, the World Health Organization, a Switzerland-based agency of the United Nations, estimated that over 35 million new cancer cases would emerge by 2050, representing a 77% rise compared to the estimated 20 million cases in 2022. Additionally, data published in November 2024 by the European Centre for Disease Prevention and Control (ECDC), a Sweden-based European Union agency, reported a total of 112,883 HIV diagnoses in 2023 across 47 out of 53 countries in the region, including 24,731 cases within the European Union/European Economic Area (EU/EEA). The overall crude rate of HIV diagnoses reached 12.7 per 100,000 population, indicating a 2.4% increase from the 12.4 per 100,000 rate observed in 2022. Thus, the growing frequency of cancer, chronic, and infectious diseases is propelling the adenosine triphosphate (ATP) assay market.

How Is The Adenosine Triphosphate (ATP) Assays Market Structured Across Different Market Segments?

The adenosine triphosphate (atp) assays market covered in this report is segmented –

1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types

2) By Component: Consumables And Accessories, Instruments

3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions

Subsegments:

1) By Luminometric ATP Assays: Luciferase-Based Assays, Chemiluminescent Assays

2) By Enzymatic ATP Assays: Kinase-Based Assays, ATPase Activity Assays

3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions, BRET For Drug Discovery

4) By Cell-Based ATP Assays: Live-Cell ATP Measurement, Cell Viability Assays

5) By Other Types: Fluorescent ATP Assays, Spectrophotometric ATP Assays

What Trends Are Driving Changes In The Adenosine Triphosphate (ATP) Assays Market?

Leading companies active in the adenosine triphosphate (ATP) assays market are concentrating on developing technologically advanced kinase testing platforms to provide highly sensitive assays. A kinase testing platform refers to a specialized system utilized for evaluating kinase activity in biological samples, which assists drug discovery and development by furnishing insights into kinase function and inhibition. For instance, in April 2024, Reaction Biology, a US-based biotechnology company, launched the HotSpotTM ATP-Max KinomeScreen, an advanced assay engineered for high-throughput kinase screening, distinguished by its increased sensitivity allowing testing at 1 mM ATP levels. This innovative platform employs a gold standard filter binding radiometric assay to assess kinase activity across the industry’s most extensive array of kinase targets. By delivering physiologically relevant data, the HotSpotTM ATP-Max KinomeScreen enables researchers to uncover more potent and specific kinase inhibitors, thereby enhancing drug discovery initiatives and facilitating the development of targeted therapies for numerous diseases, particularly cancer.

Who Are The Firms Contributing To The Adenosine Triphosphate (ATP) Assays Market Ecosystem?

Major companies operating in the adenosine triphosphate (atp) assays market are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

Access The Complete Adenosine Triphosphate (ATP) Assays Market Report:

https://www.thebusinessresearchcompany.com/report/adenosine-triphosphate-atp-assays-global-market-report

Which Region Holds The Largest Share In The Adenosine Triphosphate (ATP) Assays Market?

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Adenosine Triphosphate (ATP) Assays Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10767&type=smp

Browse Through More Reports Similar to the Global Adenosine Triphosphate (ATP) Assays Market 2026, By The Business Research Company

Protein Assays Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report

Cell Based Assays Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

In Vitro Diagnostics Enzymes Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795